Clinical Trial

Intensive Postpartum Antihypertensive Treatment

Study acronym: IPAT
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The long-term goal of our work is to evaluate the effect of intensive postpartum blood pressure control on maternal cardiovascular health, risk of chronic hypertension, and reversal of vascular dysfunction generated by hypertensive disorders of pregnancy, thus attenuating the lifelong trajectory of cardiovascular disease risk.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2023-01-16; most recent amendment 2026-07-16.
Status change: Recruiting → Active, Not Recruiting 2025-03-14
Status change: Not Yet Recruiting → Recruiting 2023-10-21
Trial Details
NCT Number NCT05687344
Lead Sponsor Medical College of Wisconsin
Conditions Hypertensive Disorder of Pregnancy
Enrollment 60 participants
Start Date 2023-09-01
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-20